Research examines iTreg stability in culture and post-cryopreservation, indicating their potential for therapy.
This study aimed to evaluate the long-term stability and cryopreservation resilience of human induced regulatory T-Cells (iTregs) in culture. Methods: CD4 T-Cells were isolated from human peripheral blood mononuclear cells (PBMCs) using magnetic separation. iTreg differentiation was induced by culturing the cells in RPMI‑1640 medium supplemented with TGF-β, IL‑2, and anti-CD3 antibodies. The proportion of cells with a CD4CD25CD127 phenotype was assessed by flow cytometry at isolation and on days 7, 14, and 21 of culture, as well as post-cryopreservation. Furthermore, the expression of key Treg markers () was analyzed at the gene level via total RNA sequencing. Results: A significant increase in the CD4CD25CD127 population was observed following induction, reaching a high purity of 96.3±2.5% by day 7, which was maintained throughout the 21-day culture period. This phenotype remained stable after cryopreservation, with no significant loss in cell numbers. RNA sequencing confirmed stable transcriptional upregulation of canonical Treg markers, including FOXP3 and IL2RA. Conclusion: Human iTregs demonstrate remarkable phenotypic and transcriptional stability over 21 days in culture and maintain their defining characteristics following cryopreservation. This confirms their suitability for long-term studies and potential therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Rzhanova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: